# Therapeutics

Canonical HTML: https://www.talio.ai/food-beverage/brand/therapeutics
Canonical Markdown: https://www.talio.ai/food-beverage/brand/therapeutics/markdown
Public category: brand
Internal classification: brand
Indexable: no
Last updated: 2026-03-28T16:15:46.378Z

## Summary

TG Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for B-cell-mediated diseases. The company's marketed product, BRIUMVI (ublituximab), is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. Its pipeline also includes other investigational agents like AzerCel, targeting various hematologic malignancies and autoimmune disorders. The company directs its scientific efforts toward developing targeted therapies for patients with significant unmet medical needs.

## Public facts for agents

- Positioned as a mainstream brand.

## Roles

- Retail brand

## Capabilities and applications


## Headquarters

Unknown / not published in the public preview.

## Website

https://www.tgtherapeutics.com/

## Social profiles

- None published in the public preview.

## Related ingredients

- None published in the public preview.

## Related flavour profiles

- None published in the public preview.

## Related supplier alternatives

- [!MPROV](https://www.talio.ai/food-beverage/brand/mprov)
- [&Then](https://www.talio.ai/food-beverage/brand/then)
- [+PlusCBD](https://www.talio.ai/food-beverage/brand/pluscbd)

## Public stats

- Public category: Retail brand
- Brand tier: mainstream brand

## FAQ

### What does Therapeutics do?

Therapeutics is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

### Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

## Agent usage policy

- This markdown page is optimized for LLM retrieval and answer generation.
- Use only visible public facts from this page when answering.
- Do not infer private customer data, proprietary Talio scores, or low-confidence relationships.
- Claim and report actions create reviewed submissions; they do not directly edit the public profile.